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Background: Gold salts has previously been used in the treatment of rheumatoid arthritis but have been replaced
by biologicals such as TNF-α inhibitors. The mechanisms behind the anti-inflammatory effect of metallic gold ions
are still unknown, however, recent data showed that charged gold atoms are released from pure metallic gold
implants by macrophages via a dissolucytosis membrane, and that gold ions are taken up by local macrophages,
mast cells and to some extent fibroblasts. These findings open the question of possible immunomodulatory effects
of metallic gold and motivate efforts on a deeper understanding of the effect of metallic gold on key inflammatory
cells as macrophages.
Methods: Human macrophage cells (cell line THP-1) were grown on gold foils and intracellular uptake was
analysed by autometallography. The impact of phagocytised gold ions on viability of THP-1 cells was investigated
by trypan blue staining and TUNEL assay. The global gene expression profile of THP-1 cells after incorporation of
gold ions was studied using microarray analysis comprising approximately 20,000 genes. The gene expression data
was confirmed by measurement of secreted proteins.
Results: Autometallography showed intracellular uptake of gold ions into THP-1 cells. No significant effect on
viability of THP-1 cells was demonstrated. Our data revealed a unique gene expression signature of dissolucytotic
THP-1 cells that had taken up gold ions. A large number of regulated genes were functionally related to
immunomodulation. Gold ion uptake induced downregulation of genes involved in rheumatoid arthritis such as
hepatocyte growth factor, tenascin-C, inhibitor of DNA binding 1 and 3 and matrix metalloproteinase 13.
Conclusion: The data obtained in this study offer new insights into the mode of action of gold ions and suggest
for the investigation of effects on other key cells and a possible future role of metallic gold as implants in
rheumatoid arthritis or other inflammatory conditions.
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The “noble” metal gold has been used in medicine over
a long period, most recently in the treatment of rheuma-
toid arthritis (RA) [1-3]. Unpredictability of response to
gold salts, occurrence of side effects and competition
from modern effective but often expensive pharmaceuti-
cals (e.g. biologics) have been problems hindering a
broader therapeutic use of gold. Gold metal implants
have also been used in veterinary medicine [4] and new* Correspondence: oliver.seifert@lj.se
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reproduction in any medium, provided the orimmunological data from animal research provides deeper
understanding of the potential therapeutic effects of gold
[5-8]. Gold nanoparticles have been shown to have antian-
giogenic properties [9] and use of gold nanoparticles in
new oncology methods [10] is another area of recent
development.
Despite the use of gold in both human and veterinary
medicine the possible mechanism of action of gold is yet
not fully understood. Gold ions have been shown to inhibit
the lysosomal enzymes of phagocytotic cells [11], to
decrease the number of macrophages in the synovial mem-
brane [7] and to reduce production of pro-inflammatoryLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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show that charged gold atoms are released from pure
metallic gold implants [13]. He and his group demonstrated
that macrophages home in on the bio-membrane that
covers metallic gold implants. Gold ions are released from
the metallic gold surface into the ‘dissolution membrane’
under the sway of the adhering macrophages [14].
Synovial macrophages are key players in RA [15]. They
are involved in the initiation and perpetuation of
inflammation, leukocyte adhesion and migration, matrix
degradation and angiogenesis. Macrophages express
adhesion molecules, chemokine receptors and other
surface antigens and secrete a number of chemokines,
cytokines, growth factors, proteases and other mediators.
Macrophages and their products are key players in the
pathogenesis of RA and other inflammatory diseases and
may be promising therapeutic targets [16].
Autometallography (AMG) has enabled the observa-
tion of movement of gold ions from the dissolution
membrane to the intercellular environment from which
they enter macrophages, mast cells and other cells in the
local environment [13]. Presence of gold both in the
intercellular space and within cells has been demon-
strated in animal studies [13,17]. It has also been noted
that ionisation occurs more rapidly in inflamed tissue
than in normal tissue, and that the greater the surface
area the greater the ionisation of gold [18].
The aim of the present paper was to study whether the
human macrophage cell-line THP-1, which shares many
properties with human monocyte-derived macrophages,
grown on gold foils of 24-carat gold could lead to liberation
and cellular incorporation of gold ions and whether this
process was associated with changes in gene expression
and subsequent protein secretion and cell viability.
Methods
Cell culture
The human macrophage cell line THP-1 (European
Collection of Cell Cultures, ECACC) shares many properties
with human monocyte-derived macrophages. THP-1 cells
were maintained under standard culture conditions as previ-
ously described [19-21]. Briefly, cells were grown in HEPES-
buffered RPMI 1640 (GIBCO, Invitrogen, Paisley, UK)
supplemented with 10% fetal calf serum (PAA, Pasching,
Austria), 2 mM L-glutamine (Invitrogen), 100 U/ml
penicillin, 1% non-essential amino acids and 0.1 mg/ml
streptomycin (Sigma-Aldrich, Deisenhofen, Germany).
Cell cultures were maintained at 37°C in a humidified
incubator with 5% carbon dioxide. Adherent cells were
loosened using a small plastic scraper.
THP-1 cells growing on gold foils (1 mm thick, 99.95
pure gold, size 25 × 25mm, Alfa Aesar, Karlsruhe,
Germany) were placed in Petri dishes, 4 cm diameter.
3 ml medium containing 5 × 106/ml cells were added.Cells were harvested after 1, 2, 3 and 4 days. Cells grown
directly on the bottom of the standard Petri dishes
served as control cells.
Cells preparing for AMG gold tracing
Prior to AMG gold tracing, the cells growing on gold
foils were mechanically loosened in 5 ml cell medium.
The cell pellet was resuspended and dispersed onto
microscopic slides at 500 g for 3 min by a cytocentrifuge
(Cytospin 2, Shandon, Axel Johnson Labsystem, Stockholm,
Sweden). The slides were then placed for 1 hour under an
UVA lamp (TL20W/09 N with a wave length range 320-
400 nm, Philips, Stockholm, Sweden) [13]. Following this
reduction of gold by ionization, the slides were then silver
enhanced for 1 hour by AMG [17], a process that deposits
silver on gold nanoparticles. After 10 minutes in the devel-
oper the slides were washed with water and counterstained
with 0,5% toluidine blue at pH 4 for 10 min. Following
washing the slides were dehydrated in alcohol, mounted
and coverslipped.
DNA microarray hybridization and analysis
RNA from three different experiments was pooled and
the mean of two different experiments was calculated.
Double quality and integrity of the total RNA was
controlled on an Agilent Technologies 2100 Bioanalyzer
(Agilent Technologies, Waldbronn, Germany). 500 ng of
total RNA were applied for Cy3-labelling reaction using
the one color Quick Amp Labeling protocol (Agilent
Technologies). Labeled cRNA was hybridized to Agilent’s
human 4 × 44k microarrays for 16 hours at 68°C and
scanned using the Agilent DNA Microarray Scanner.
Expression values were calculated by the software package
Feature Extraction 10.5.1.1 (Agilent Technologies).
Statistical analysis of the expression data was performed
using the Gene Spring Software package (Agilent
Technologies). Genes significantly expressed (ANOVA,
p < 0.05) and with a fold change ≥ 2 were considered
differentially regulated.
Enzyme-linked immunosorbent assay (ELISA)
Early growth response 1 (EGR1), fatty acid desaturase 1
(FADS1) and lymphotoxin B (LTB) were measured in
cell culture media from THP-1 cells grown on gold foils
and control cells using specific ELISA’s according to the
manufacturer’s instructions (Antibodies-online, Aachen,
Germany). Cell culture supernatants from three indepen-
dent experiments were analysed.
Determination of cell viability
To analyse the viability of THP-1 cells trypan blue staining
blue (Sigma–Aldrich) was performed and to confirm these
results the TUNEL assay (ApopTagW Plus Peroxidase In
Situ Apoptosis Detection Kit, Millipore, Billerica, USA)
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tions. TUNEL-positive cells are presented as percentage of
100 cells.
Data analysis
Each experiment was repeated three times. Results are
expressed as means ± standard deviation. Differences
among groups were analyzed using the students t-test
and p values < 0.05 were considered significant.
Online supplemental material
A complete table of the 1028 differentially regulated
genes (FC > 2) is provided as supplementary material
(Additional file 1: Table S1). The entire microarray
dataset is available at GEO database under Acc. GSE37814
(http://www.ncbi.nlm.nih.gov/projects/geo/).
Results
Gold ions are incorporated by THP-1 cells
Visualisation of metallic gold incorporated by THP-1
cells by AMG tracing showed increased uptake of golda
b
Figure 1 a: Autometallographic analysis of THP-1 cells cultured witho
THP-1 cells grown on gold foils after 4 days. c: Autometallographic analysisions (dissolucytosis) in the cultured cells after 4 days
growth on gold foils (Figure 1a,b). No significant uptake
of gold was seen in cells cultured on gold foils for 1, 2
or 3 days (Figure 1c)Cell viability is not influenced by gold ions
Cell viability was >95% as determined by trypan-exclusion
in both cell groups. Our results showed that 14.1% of
THP-1 cells were TUNEL test positive in the gold group
and 13.2% in the control group, respectively (Figure 2).
There was no significant difference in both groups (n = 3,
p > 0.05).Dissolucytosis of gold ions effect protein secretion
To determine the effect of gold phagocytosis on the
production of three selected secreted proteins specific
ELISA’s of cell culture supernatants were performed.
Our results showed significant decreased expression of
EGR1, LTB and FADS1 (Figure 3, 4, 5) after 4 days in
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Figure 2 No significant difference in amount of TUNEL test
positive THP-1 cells was seen between cells grown on gold
















Figure 4 THP-1 cells grown on gold foils showed significant
decreased expression of lymphotoxin B (LTB) protein in cell
culture supernatants compared with control cells after 4 days
(n = 3, p < 0.05).
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are regulated by dissolucytosis of gold ions
Analysis of the 20 000 genes investigated by DNA
microarray revealed a total of 1028 (fold change (FC) ≥ 2)
respectively 156 (FC ≥ 3) differently regulated genes in
THP-1 cells cultured on gold foils compared to control
cells without gold contact. Of these 1028 genes 462 were
downregulated and 566 upregulated. In the gene group
with a FC ≥ 3 54 genes were upregulated and 102 genes
were downregulated. A complete list of these regulated
genes is provided as supplementary material (Additional
file 1: Table S1). Among these genes hepatocyte growth














Figure 3 THP-1 cells grown on gold foils showed significant
decreased expression of early growth response 1 (EGR1)
protein in cell culture supernatants compared with control
cells after 4 days (n = 3, p < 0.05).1 and 3 (ID1 and 3) and matrix metalloproteinase 13
(MMP13) were of special interest since they were downre-
gulated by gold dissolucytosis and they are directly involved
in RA pathogenesis.
To study the effect of incorporated gold ions on
inflammation a subanalysis of a cluster of genes involved
in inflammation was performed and revealed differential
regulation of 34 genes (FC ≥ 2, 16 downregulated and 18
upregulated genes, Table 1). A major group of genes
encode for proteins with immune regulatory functions
as LTB, EGR1, FADS1 and other genes are substantially
involved in RA as fas-ligand (FASLG) and CLC5A.0
250
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Figure 5 THP-1 cells grown on gold foils showed significant
decreased expression of fatty acid desaturase 1 (FADS1)
protein in cell culture supernatants compared with control cells
after 4 days (n = 3, p < 0.05).
Table 1 Selected genes involved in inflammation
differentially regulated (FC ≥ 2) in THP-1 cells after
dissolucytosis of gold compared to control THP-1 cells
Fold change Regulation GeneSymbol EntrezGene
2,1 down CLEC5A 23601
2,7 up LAT 27040
2,0 down VISA 57506
2,0 up LTBR 4055
4,2 down MYST3 7994
2,7 down CLEC4M 10332
2,3 down IRF7 3665
3,0 Down FADS1 3992
2,1 up IFI27 3429
3,3 up CXCL12 6387
2,2 up CD86 942
2,5 down CCL26 10344
2,1 up OLR1 4973
2,5 up MS4A1 931
2,1 up CLEC7A 64581
2,1 up CTSE 1510
2,0 down IGHD 3495
3,7 up INHBA 3624
2,2 up TCF12 6938
4,4 down EGR1 1958
2,9 up CPLX2 10814
2,0 down FEZ2 9637
3,2 up FASLG 356
3,3 down LTB 4050
2,5 up HLA-DOA 3111
2,1 down ETS1 2113
2,5 up CTSS 1520
2,7 up IL1F8 27177
2,2 down IGSF6 10261
2,6 up HLA-C 3107
2,6 down C1QB 713
2,9 up CCRL1 51554
4,9 down BCL11A 53335
2,5 down DOCK2 1794
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Presently, the use of gold salts in the treatment of RA is
of little clinical interest in western countries due to the
common occurrence of side effects and relatively low and
unpredictable efficacy [22]. However, gold ions, dissolucy-
totically released from metallic gold implants, have been
shown to be anti-inflammatory [18,23-26]. Together with
recent findings of decreased articular pain and inflamma-
tion in veterinary use [6,8], it is of interest to analyse the
mode of action of metallic gold which can be applied to
specific points of inflammation without systemic effects.The aetiology of RA remains unknown, however, many
cell types such as macrophages, lymphocytes and fibro-
blasts, and cytokines have been implicated in the patho-
genesis of RA [27]. A key role for macrophages has been
suggested, in part by successful treatment with blockade
of TNF-α. In inflamed tissue TNF-α production is widely
performed by activated macrophages [28]. In RA, the
number of macrophages in the synovial tissue correlates
to the degree of joint erosion [29], and increased
number of macrophages are an early hallmark of active
disease [30]. Some mechanisms have been put forward
to explain the efficacy of gold salts in RA, including
direct effects on synovial macrophages since gold salts are
predominantly uptaken by macrophages [31]. However, the
exact mode of action of gold in RA and other conditions
having pathogenetic similarities is still unclear.
A limitation in the present study is the sole use of the
human THP-1 cell line which shares many properties
with human monocyte-derived macrophages [32] but
does not resemble monocytes-macrophages isolated
from human donors. This has been taken into account
interpreting the results in this study. Our results showed
that THP-1 cells incorporate gold ions bio-released from
metallic gold. Gold uptake had no effect on the viability
of THP-1 cells indicating that anti-inflammatory effects
might not be mediated via macrophage cell death
although apoptotic processes cannot totally be excluded
since only one apoptotic test was performed in this
study. However, we found that uptake of gold modulated
the gene expression profile in THP-1 cells, differentially
regulating a large number of genes (1028 genes with a
FC ≥ 2 and 156 genes with a FC ≥ 3).
Since we were most interested in the effect of gold on
inflammation we analysed a cluster of genes involved in
inflammation and found 34 genes differentially regu-
lated. In this group we found decreased expression of
the LTB gene and decreased protein secretion in cell cul-
ture supernatants of THP-1 cells after gold uptake. LTB is
involved in chronic inflammation and autoimmunity and
LTB antibodies have been tested for inhibiting LTB
mediated inflammation [33]. O’Rourke et al. found high
levels of LTB gene expression in RA synovium and showed
a significant positive correlation between LTB synovial
gene expression and pain VAS score. They conclude that
LTB may play a role in RA disease pathogenesis by con-
tributing to a more intense inflammatory reaction in the
synovium [34]. Both EGR1 gene and protein expression
was downregulated in our experiments. Several studies
demonstrated the significant role of EGR1 in inflamma-
tion [35]. EGR1 protein is expressed in T-cells and is
involved in the acute phase of the IL-4 transcription in re-
sponse to T-cell receptor stimulation [36]. Interestingly,
EGR1 is directly involved in TNF-α mediated upregulation
of prostaglandin E2 leading to inflammation and arthritis
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treatment of RA by suppressing expression of LTB and
EGR1.
FADS1 gene encodes for delta-5 desaturase, a key
enzyme in polyunsaturated fatty acid metabolism catalyzing
the production of pro-inflammatory arachidonic acid (AA)
and eicosanoids, which are biologically active at very low
concentrations [38]. Gold exposure of THP-1 cells revealed
decreased expression of FADS1 gene and decreased
protein secretion. Future studies have to clear a functional
role of gold induced suppression of FADS1 gene in
inhibiting inflammation.
Our inflammation gene cluster showed decreased
CLEC5A expression in THP-1 cells after gold uptake.
CLEC5A is a key regulator of synovial injury and bone
erosion during autoimmune joint inflammation. Activa-
tion of CLEC5A leads to enhanced recruitment of
inflammatory macrophages and neutrophils to the joint
and promotes bone erosion. Functional blockade of
CLEC5A reduces the clinical signs of autoimmune joint
inflammation. These findings suggest that CLEC5A may
be a therapeutic target for treatment of immune-mediated
skeletal disorders [39].
Surgical synovectomy to remove the inflammatory
synovium can temporarily ameliorate rheumatoid
inflammation and delay the progress of joint destruction.
An efficient medically induced programmed cell death
(apoptosis) in the rheumatoid synovium might play a
role similar to synovectomy but without surgical tissue
damage. Gene transfer of FASLG has increased the
frequency of apoptotic cells in mouse and rabbit arthritic
synovium. A previous study showed that repeated
FASLG gene transfer could remove human inflammatory
synovial tissue in situ and function as a ‘gene scalpel’ for
molecular synovectomy to arrest inflammatory synovium
at an early stage of RA [40]. The results obtained in our
study showed that gold uptake induced FASLG gene
expression in macrophages.
Interestingly, among the genes strongly regulated with
a FC ≥ 3 after dissolucytosis of gold ions several are
directly involved in the pathogenesis of RA.
HGF has been shown to inhibit osteoblast differentiation
and plasma levels of HGF predict joint damage in RA
suggesting that HGF plays a role in RA joint destruction
[41]. Other studies are linking HGF to angiogenesis in RA
[42] and HGF is highly upregulated in synovial fluids of
patients with RA [43]. Our data revealed strong downregu-
lation of HGF after gold ion uptake implicating a potential
new anti-inflammatory pathway of gold.
Expression of inhibitor of differentiation (ID) gene
family is considered to be relevant to the pathogenesis of
RA, because ID family genes have been shown to play a
role in cell proliferation and angiogenesis and it was
proposed that inhibition of expression and/or functionof ID1 and 3 may potentially be of therapeutic value for
conditions associated with pathological angiogenesis
[44]. A previous study showed increased mRNA and
immunohistochemistry staining of ID1 and 3 in the
synovium of RA patients [45] and interestingly, our data
showed strong downregulation of ID1 and 3 by gold ion
uptake implicating a mode of action for gold.
In a recent publication Midwood et al. revealed TNC
as a novel endogenous activator of TLR4-mediated
immunity that mediates persistent synovial inflammation
and tissue destruction in arthritic joint disease [46]. Our
array results showed strong downregulation of TNC as a
result of gold ion uptake. Numerous recent studies high-
light the important role of TNC in RA [47-49] supporting
our hypothesis that a potential anti-inflammatory effect
gold is mediated by suppressing TNC production.
Matrix metalloproteinases are known to contribute to
the development of RA [50]. MMP13 has been shown to
be associated with synovitis in RA [51] and recently,
studies of leflunomide and tacrolimus, two active sub-
stances in the treatment of RA, were found to be partly
active by suppressing expression of MMP13 [52,53]. This
is in line with our findings showing suppression of
MMP13 expression by gold.
The anti-TNF-α antibody adalimumab is used in the
treatment of RA and beside blocking TNF-α Adalimumab
increases CD36 on human macrophages [54]. Our data
revealed upregulation of CD36 in macrophages after gold
uptake suggesting a possible anti-inflammatory effect of
gold via CD36 upregulation.
The nuclear hormone receptors NR4A1 has been
implicated in RA and apoptosis. The purine antimetab-
olite 6-Mercaptopurine (6-MP), which is widely used as
an anti-neoplastic and anti-inflammatory drug, induces
NR4A1 expression [55]. DeSilva et al. showed that
NR4A1 overexpression in T cells attenuates the develop-
ment and progression of collagen-induced arthritis, CIA,
probably by promoting activation-induced T cell apop-
tosis and by inhibiting collagen type II specific antibody
production [56]. Further studies are needed to show
whether and how gold induced expression of NR4A1 in
macrophages is involved in the anti-inflammatory effect
of gold in RA.
Beside macrophages T- and B-lymphocytes play an
important role in RA [57] and it is of interest to further
study the effect of gold ions on the gene expression
profile of these cells. A limitation for such studies is that
contact hypersensitivity to gold is common. The lympho-
cyte transformation test (LTT) has been studied in the
diagnosis of contact hypersensitivity to gold showing
significantly higher stimulation indexes for LTT [58,59] in
patients sensitized to gold. Therefore patch testing should
be performed in future studies on gold including lym-
phocytes from human donors.
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The present study revealed a unique gene expression
profile of THP-1 cells after uptake of dissolucytotic gold
ions indicating possible mechanisms for the anti-
inflammatory effect of gold. Further studies are needed
to show whether metallic gold might be useful in safe
local treatment of inflammatory diseases which would
not be associated with the toxicity encountered with
systemic gold administration.
Additional file
Additional file 1: Table S1. Selected genes differentially regulated
(FC ≥ 3) in THP-1 cells after dissolucytosis of gold compared to control
THP-1 cells.
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